BioGenex Laboratories Inc. has announced that it has received Pre-Market Approval from the FDA for its InSite™ HER-2/neu (CB11) Monoclonal Antibody. This antibody is used in tests to identify breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results